RECRUITING

Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study seeks to evaluate the use of intermittent dosing as an alternative paradigm for patients with DRG stimulation in place for at least 1 year and minimum 50% pain relief in the targeted area. Patients will be prospectively randomized to one of two stimulation paradigms both of which involve intermittent dosing at 30 seconds ON and 90 seconds OFF. Group 1 will have their frequency set at 20 Hz with amplitude levels adjusted in order to remain in the therapeutic window (subthreshold stimulation). Group 2 will have their frequency set at 5 Hz with amplitude levels adjusted in order to remain in the therapeutic window (subthreshold stimulation) This study will be performed in a crossover fashion, meaning patients will be changed to the alternate dosing regimen at the 13-week time period. Patients will be seen and evaluated prior to randomization and reprogramming, and thereafter evaluated at 4, 8, and 12-weeks. At the 12-week time period, patients will begin a 1-week washout period of continuous stimulation. At the 13-week time period, patients will be evaluated, crossed over to the other study arm and thereafter evaluated at 17, 21, and 25-weeks.

Official Title

Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy

Quick Facts

Study Start:2022-10-15
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04909138

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age between 18 and 99
  2. * 1-year or more use of continuous DRG therapy as delivered a permanently implanted Abbott PROCLAIM XR Dorsal Root Ganglion Neurostimulator System for chronic back and/or leg pain
  3. * Endorse at least 50% pain relief in the targeted area over the last year
  4. * Must have been seen for routine follow-up within last 4 months
  5. * Must have been reprogrammed in standard fashion at least once prior to randomization
  6. * Willing and able to complete protocol requirements, including:
  7. * Complete health questionnaires and pain scales as specified in the protocol
  8. * Sign the study-specific informed consent form
  9. * Complete follow-ups at the designated time periods
  1. * Significant lead migration, as determined by clinician
  2. * Other concurrent neuromodulation system in place
  3. * Corticosteroid injection in previous 30 days prior to enrollment
  4. * Intermittent dosing and/or failure within last 6m
  5. * Changing or unstable pain medications within 30 days

Contacts and Locations

Study Contact

Timothy Lubenow, MD
CONTACT
3129422966
Timothy_R_Lubenow@rush.edu
Daniel Torrez, BS
CONTACT
312942-2741
Daniel_Torrez@rush.edu

Principal Investigator

Robert McCarthy, PharmD
STUDY_DIRECTOR
Rush University Medical Center

Study Locations (Sites)

Rush University Medical Center
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: Rush University Medical Center

  • Robert McCarthy, PharmD, STUDY_DIRECTOR, Rush University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-15
Study Completion Date2026-06

Study Record Updates

Study Start Date2022-10-15
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • Chronic Pain
  • Dorsal Root Ganglion Stimulation

Additional Relevant MeSH Terms

  • CRPS (Complex Regional Pain Syndromes)
  • Radiculopathy
  • Peripheral Neuropathy